| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2593578 | Reproductive Toxicology | 2013 | 8 Pages |
The embryonic stem cell test (EST) is based on compound-induced inhibition of cardiomyocyte differentiation of pluripotent stem cells. We examined the use of transcriptomics to assess concentration–effect relationships and performed potency ranking within a chemical class. Three embryotoxic phthalate monoesters, monobutyl phthalate (MBuP), monobenzyl phthalate (MBzP) and mono-(2-ethylhexyl) phthalate (MEHP) and the non-embryotoxic monomethyl phthalate (MMP) were studied for their effects on gene expression. Effects on gene expression were observed at concentrations that did not inhibit cardiomyocyte differentiation or induce cytotoxicity. The embryotoxic phthalate monoesters altered the expression of 668 commonly expressed genes in a concentration-dependent fashion. The same potency ranking was observed for morphology and gene expression (MEHP > MBzP > MBuP > MMP). These results indicate that integrating transcriptomics provides a sensitive method to measure the dose-dependent effects of phthalate monoester exposure and enables potency ranking based on a common mode of action within a class of compounds. Transcriptomic approaches may improve the applicability of the EST, in terms of sensitivity and specificity.
► We assessed dose-dependent effects of phthalates on cell proliferation, differentiation and gene expression profiling using embryonic stem cells. ► Significant dose effects were observed both on gene expression of overlapping genes between embryotoxic phthalates and biological processes. ► Gene expression was used for potency ranking within a class of compounds. ► Transcriptomics showed to be a sensitive and wide-ranging parameter contributing to the understanding of mode of action of compounds.
